Dr. Reddy's intros generic Strattera
Dr. Reddy’s Laboratories announced the launch of its atomoxetine capsules.
The product, which is indicated for the treatment of attention-deficit/hyperactivity disorder, is a generic version of Eli Lilly’s Strattera.
Dr. Reddy’s atomoxetine capsules are available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg, with a 30-count bottle size.
Both the Strattera brand and generic had a market value of approximately $304 million for the most recent 12 months ending in August 2018, according to IQVIA data.
The product, which is indicated for the treatment of attention-deficit/hyperactivity disorder, is a generic version of Eli Lilly’s Strattera.
Dr. Reddy’s atomoxetine capsules are available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg, with a 30-count bottle size.
Both the Strattera brand and generic had a market value of approximately $304 million for the most recent 12 months ending in August 2018, according to IQVIA data.